indacrinone has been researched along with Alzheimer Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Fang, T; Jiang, T; Qiao, J; Xu, Y | 1 |
| Bansal, R; Rana, P; Singh, R | 1 |
| Abibiglue, YT; Bavili, A; Dastmalchi, S; Etemadi, A; Hamzeh-Mivehroud, M; Hemmati, S; Shahrivar-Gargari, M | 1 |
| Albertini, C; Bartolini, M; Bolognesi, ML; de Sena Murteira Pinheiro, P; Di Pietri, F; Fato, R; Perone, R; Petralla, S; Pulkrabkova, L; Rizzardi, N; Soukup, O; Tramarin, A; Uliassi, E | 1 |
| Huang, L; Li, X; Meng, F; Miao, H; Sun, Y | 1 |
| Andrisano, V; Bartolini, M; Cavalli, A; Ceccarini, L; Gobbi, S; Piazzi, L; Rampa, A; Recanatini, M; Rizzo, S | 1 |
| Huang, L; Li, XS; Mao, F; Meng, FC; Qin, F; Shan, WJ | 1 |
| Gan, CS; Ge, JF; Nan, DD; Pan, J; Qiao, JP; Wang, CW; Zhou, JN | 1 |
8 other study(ies) available for indacrinone and Alzheimer Disease
| Article | Year |
|---|---|
Multi-fluorine labeled indanone derivatives as potential MRI imaging probes for β-Amyloid plaques.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Fluorine; Humans; Indans; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Plaque, Amyloid; Tissue Distribution | 2023 |
Synthesis,
Topics: Alzheimer Disease; Animals; Indans; Lipopolysaccharides; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Rats; Structure-Activity Relationship | 2023 |
Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amines; Butyrylcholinesterase; Cholinesterase Inhibitors; Donepezil; Humans; Indans; Molecular Docking Simulation; Structure-Activity Relationship | 2023 |
Turning Donepezil into a Multi-Target-Directed Ligand through a Merging Strategy.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Blood-Brain Barrier; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Donepezil; Drug Design; Humans; Indans; Ligands; Neuroprotective Agents; Oxidative Stress; Protein Aggregates; Structure-Activity Relationship | 2021 |
Discovery of indanone derivatives as multi-target-directed ligands against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Humans; Indans; Inhibitory Concentration 50; Ligands; Peptide Fragments; Permeability; Protein Aggregates | 2014 |
Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Binding Sites; Bleomycin; Cholinesterase Inhibitors; Computer Simulation; Coumarins; Donepezil; Humans; Indans; Lomustine; Methotrexate; Peptide Fragments; Piperidines; Recombinant Proteins; Stilbenes; Structure-Activity Relationship; Tetrahydronaphthalenes | 2010 |
Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents.
Topics: Acetylcholinesterase; Alzheimer Disease; Chelating Agents; Cholinesterase Inhibitors; Drug Design; Humans; Indans; Kinetics; Metals; Pyridines; Structure-Activity Relationship | 2012 |
Novel indanone derivatives as potential imaging probes for β-amyloid plaques in the brain.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Humans; Indans; Male; Mice; Mice, Inbred ICR; Molecular Imaging; Molecular Probes; Plaque, Amyloid; Radiopharmaceuticals; Tissue Distribution | 2012 |